ISDA

Deposition Date 2006-06-17

Release Date 2007-06-19

Last Version Date 2023-10-25

Entry Detail

PDB ID:

2DS1

Keywords:

TRANSFERASE

Title:

Human cyclin dependent kinase 2 complexed with the CDK4 inhibitor

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Spodoptera frugiperda

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.00 Å

R-Value Free:

0.28

R-Value Work:

0.22

Space Group:

P 21 21 21

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Cell division protein kinase 2
Gene (Uniprot):CDK2
Mutations:F82H, L83V, K89T
Chain IDs:A
Chain Length:298
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:P24941 Pfam ID:PF00069 EC:2.7.11.22

Ligand Molecules

1CD

Primary Citation

Structure-based drug design of a highly potent CDK1,2,4,6 inhibitor with novel macrocyclic quinoxalin-2-one structure

Kawanishi, N, Sugimoto, T, Shibata, J, Nakamura, K, Masutani, K, Ikuta, M, Hirai, H.Show

Bioorg.Med.Chem.Lett. 16 5122 5126 (2006)

PMID: 16876403 DOI: 10.1016/j.bmcl.2006.07.026

Abstact

The design of a novel series of cyclin-dependent kinase (CDK) inhibitors containing a macrocyclic quinoxaline-2-one is reported. Structure-based drug design and optimization from the starting point of diarylurea 2, which we previously reported as a moderate CDK1,2,4,6 inhibitor [J. Biol.Chem.2001, 276, 27548], led to the discovery of potent CDK1,2,4,6 inhibitor that were suitable for iv administration for in vivo study.

Legend

Protein

Chemical

Disease

Primary Citation of related structures